Vimarsana
Biggest News Aggregation in the World

Rahim Fandi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rahim Fandi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rahim Fandi Today - Breaking & Trending Today

Oxford BioTherapeutics Announces Collaboration with Agenus to Support the Clinical Development of OBT's Antibody Drug Conjugate OBT076 in combination with Agenus' CPI Balstilimab - Vimarsana News

Oxford BioTherapeutics Announces Collaboration with Agenus to Support the Clinical Development of OBT's Antibody Drug Conjugate OBT076 in combination with Agenus' CPI Balstilimab

Published: May 25, 2022

New deal enables Oxford BioTherapeutics (OBT) to evaluate OBT076 with a checkpoint inhibitor (CPI) in both CPI-naïve and resistant patientsOBT076 has previously shown preliminary signs of clinical

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomEleanor PerkinRahim FandiGeorge UnderwoodPrnewswire Oxford BiotherapeuticsChristian RohlffSylvie BerrebiOxford BiotherapeuticsAlere AbbottBoehringer IngelheimAgenus IncAntibody Drug ConjugateChief Executive OfficerSteveno DayChief Medical OfficerSan JoseKite PharmaDavid Dible
AACR 2022: Oxford BioTherapeutics to Present Potential Novel Immuno-Oncology Mechanism in Combination with Checkpoint Inhibitors for Experimental ADC Medicine OBT076 - Vimarsana News

AACR 2022: Oxford BioTherapeutics to Present Potential Novel Immuno-Oncology Mechanism in Combination with Checkpoint Inhibitors for Experimental ADC Medicine OBT076

Published: April 7, 2022

Initial data from the Phase 1 dose escalation part of the OBT076 trial in adult patients with advanced solid tumors indicated that OBT076 had a favorable...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomRahim FandiOxford BiotherapeuticsAlere AbbottChristian RohlffSylvie BerrebiBoehringer IngelheimAmerican Association Of Cancer ResearchClinical DevelopmentImmune ResponseImmune MonitoringClinical CorrelatesAntibody Drug ConjugateExpansion Phasei TrialAmerican AssociationCancer ResearchAnnual MeetingNew OrleansChief Executive OfficerChief Medical OfficerPotential Novel Immuno Oncology MechanismGastric CancerPoster SectionClinical Development Plans